Edwards Lifesciences Corp. (EW) Tops Q2 EPS by 2c; Guides Q3 Below the Street

July 24, 2012 4:02 PM

Edwards Lifesciences Corp. (NYSE: EW) reported Q2 EPS of $0.67, $0.02 better than the analyst estimate ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found